A detailed history of Rathbones Group PLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 73,154 shares of IOVA stock, worth $806,888. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,154
Previous 73,154 -0.0%
Holding current value
$806,888
Previous $1.08 Million 45.94%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$7.59 - $17.47 $15,180 - $34,940
2,000 Added 2.81%
73,154 $1.08 Million
Q3 2023

Nov 13, 2023

BUY
$4.44 - $8.79 $315,923 - $625,443
71,154 New
71,154 $323,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.74B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.